EGF Knockout HEK293 Cell Line
Cat.No.:
EDC08274
Species:
Human
Cell Name:
HEK293
Gene:
EGF
Gene ID:
1950
Size:
1×10⁶cells
EGF Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08274 |
|---|---|
| Product Name | EGF Knockout Cell Line (HEK 293) |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | EGF |
| NCBI Gene ID | |
| Gene Synonyms | HOMG4|URG |
| Summary |
This gene encodes a member of the epidermal growth factor superfamily. The encoded preproprotein is proteolytically processed to generate the 53-amino acid epidermal growth factor peptide. This protein acts a potent mitogenic factor that plays an important role in the growth, proliferation and differentiation of numerous cell types. This protein acts by binding with high affinity to the cell surface receptor, epidermal growth factor receptor. Defects in this gene are the cause of hypomagnesemia type 4. Dysregulation of this gene has been associated with the growth and progression of certain cancers. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/5,2days |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete culture medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying EGF function, EGF Knockout HEK293 Cell Line or EGF overexpression HEK293 Cell Line?
The choice depends on whether you are studying EGF (epidermal growth factor)'s role as the prototypical EGFR ligand or its functions in autocrine/paracrine signaling. The Knockout line is the standard tool for asking whether EGF is required for autocrine EGFR signaling — EGF is a 53-amino-acid secreted growth factor (processed from the larger pre-pro-EGF precursor) that binds EGFR (ERBB1) with high affinity, triggering receptor dimerization, autophosphorylation, and downstream PI3K-AKT and RAS-MAPK signaling. Overexpression is useful for studying EGF gain-of-function effects.
For EGF-EGFR pathway research, the EDITGENE EGF Knockout in HEK293 enables study of autocrine EGF production. Rescue with wild-type or receptor-binding-deficient EGF enables structure-function studies. The knockout is valuable for studying autocrine EGF signaling, EGFR-targeted cancer therapeutic specificity (cetuximab, panitumumab anti-EGFR antibodies; gefitinib, erlotinib, osimertinib EGFR-TKIs), and emerging EGF-modulating therapeutic strategies.
What are the application scenarios for this model?
Primary applications:
• EGF secretion: secreted EGF quantification by ELISA in conditioned media to characterize autocrine EGF production.
• Autocrine EGFR signaling: phospho-EGFR (Y1068, Y1173), phospho-ERK analysis in EGF-null cells.
• Anti-EGFR therapy specificity: complementary specificity control for cetuximab (Erbitux), panitumumab (Vectibix) anti-EGFR antibody specificity testing.
• EGFR-TKI mechanism: gefitinib, erlotinib, osimertinib mechanism studies with reduced autocrine EGF.
EDITGENE recommends this model for researchers investigating EGF biology, autocrine EGFR signaling, and EGF-EGFR pathway therapeutic development.
Is this EGF Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes. EGF rescue experiments require attention to secreted growth factor processing:
• Construct design: EGF is processed from a large pre-pro-EGF precursor (1207 aa) into the mature 53-aa secreted polypeptide — use untagged EGF and quantify secreted form by ELISA, or use precursor with internal tag carefully placed away from the EGF domain.
• Secretion validation: confirm conditioned media EGF levels by ELISA before functional assays.
• Receptor-binding-deficient rescue: EGFR-binding residue mutations in the mature EGF abolish EGFR activation.
• Functional readout: rescue should restore conditioned-media EGF levels and autocrine EGFR activation.
HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download